Surgical Management of the Axilla in Clinically Node-Positive Breast Cancer Patients Converting to Clinical Node Negativity through Neoadjuvant Chemotherapy: Current Status, Knowledge Gaps, and Rationale for the EUBREAST-03 AXSANA StudyMaggie Banys‐Paluchowski, Oreste Gentilini, Elmar Stickeler et al.|Cancers|2021Cited by 159
Axillary evaluation in ductal cancer <i>in situ</i> of the breast: challenging the diagnostic accuracy of clinical practice guidelinesAndreas Karakatsanis, Peter Stålberg, Petros Charalampoudis et al.|British journal of surgery|2021Cited by 3